Comment on: Bacteraemia with an MBL-producing Klebsiella pneumoniae: treatment and the potential role of cefiderocol heteroresistance

J Antimicrob Chemother. 2022 Sep 30;77(10):2895-2896. doi: 10.1093/jac/dkac277.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't
  • Comment

MeSH terms

  • Anti-Bacterial Agents / pharmacology
  • Anti-Bacterial Agents / therapeutic use
  • Bacteremia* / drug therapy
  • Cefiderocol
  • Cephalosporins / pharmacology
  • Cephalosporins / therapeutic use
  • Humans
  • Klebsiella Infections* / drug therapy
  • Klebsiella pneumoniae
  • Microbial Sensitivity Tests
  • beta-Lactamases / genetics

Substances

  • Anti-Bacterial Agents
  • Cephalosporins
  • beta-Lactamases

Grants and funding